Ban Those Annoying and Dangerous Pharmaceutical Drug Commercials (Opinion)
- Health and Human Services Secretary Robert F. Kennedy Jr. aims to restrict pharmaceutical advertisements and increase transparency about side effects, as companies currently spend about $10.8 billion on advertising annually.
- BlazeTV host Sara Gonzales criticizes many pharmaceutical commercials, believing they mislead consumers by promoting quick fixes instead of encouraging healthier lifestyle choices.
- Kennedy's initiative seeks to enhance public trust through rigorous oversight of drug promotions, pending tax policy changes that could be announced soon.
12 Articles
12 Articles


RFK Jr. targets prescription drug ads
The Trump administration is discussing policies that would make it harder and more expensive for pharmaceutical companies to advertise directly to patients, a move that could disrupt more than $10 billion in annual ad spending.


Ban those annoying and dangerous pharmaceutical drug commercials (Opinion)
Big Pharma invests billions to try to convince you that they know better than doctors about your health. RFK Jr.'s plan to ban pharmaceutical drug commercials would help.
Will Trump and Kennedy Rein in Big Pharma Advertising?
(Liberty Nation)—The Trump administration is mulling policies to make it more difficult and costly for pharmaceutical companies to promote prescription drugs directly to consumers. Big Pharma spends billions on advertising to promote sales, yet not all of its products are necessary or even safe, contributing to the overmedication of many Americans. Concerns about the industry’s excessive influence on news reports, enabled by their mighty purse s…
Kennedy sets a higher bar for pharmaceuticals: This is What Modernization Should Look Like
James Lyons-Weiler What People, Universities, and Pharma Do Not Yet Understand About the Kennedy Regulatory Bar: It Signals the End of the Regulatory States of America. Science must outlive the PR cycle. Modernization, as used today by industry lobbyists and public health officials, often amounts to a euphemism for deregulation: fewer checks, less transparency, and faster product pipelines with fewer questions asked. In contrast, Secretary Rober…
Coverage Details
Bias Distribution
- 50% of the sources lean Right
To view factuality data please Upgrade to Premium